H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

Two doses of AS03B-adjuvanted pandemic influenza vaccine may be sufficient to maintain seroprotection across 2 influenza seasons. Administration of trivalent influenza vaccine to children who previously received 2 doses of pandemic influenza vaccine is safe and is immunogenic for the H1N1 strain.

Bibliographic Details
Main Authors: Walker, Woolf T., de Whalley, Philip, Andrews, Nick, Oeser, Clarissa, Casey, Michelle, Michaelis, Louise, Hoschler, Katja, Harrill, Caroline, Moulsdale, Phoebe, Thompson, Ben, Jones, Claire, Chalk, Jem, Kerridge, Simon, John, Tessa M., Okike, Ifeanyichukwu, Ladhani, Shamez, Tomlinson, Richard, Heath, Paul T., Miller, Elizabeth, Faust, Saul N., Snape, Matthew D., Finn, Adam, Pollard, Andrew J.
Format: Online
Language:English
Published: Oxford University Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275760/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275760/

Similar Items